The RSV vaccine protects adults against serious sickness and death.

• Identifies high effectiveness in older adults, even those with immunocompromised conditions.
• Provides 80% protection against disease, hospitalization, ICU admission, and respiratory infection death.
• Protects against less severe disease in adults not requiring hospitalization.